Submitted by Anonymous (not verified) on 25 November 2024 - 13:27
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Date of authorisation: 12/01/2023, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Date of authorisation: 12/01/2023, Revision: 3, Status: Authorised